Indian trial compensation guidelines open to comment
India is seeking comments on draft guidelines that detail sponsors’ clinical trial injury compensation responsibilities.
India is seeking comments on draft guidelines that detail sponsors’ clinical trial injury compensation responsibilities.
in-PharmaTechnologist presents its round-up of the latest drug delivery research developments in the pharmaceutical world, including tumour targeting peptides and lipid nanoparticle drug-delivery technology.
Fear of getting “lost in the shuffle” makes some biotechs nervous about outsourcing to big CROs, a Covance VP said.
The requirement for local clinical trials has been a ‘serious blow’ to Russia’s drug approval system and an opportunity for unethical CROs according to the Moscow-based Association of Clinical Trial Organisations (ACTO).
Industry reluctance to share information on economic adulteration is hindering FDA efforts to tackle tainted ingredients, a GAO report found.
Generic drugs manufacturer SOHM is continuing its expansion into the Indian market with the acquisition of Novatrend Medicament’s product line.